MedTrace Logo

Lymphangioleiomyomatosis, a Study on Cathepsin K

NCT05323370 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2023-03-29

No results posted yet for this study

Summary

This is a physiopathological case-control, non-interventional, monocentric study of adult patients with lymphangioleiomyomatosis. The controls are patients followed in neurology at the CHU of Tours for a tuberous sclerosis complex without lymphangioleiomyomatosis, the healthy volunteers are women with neither pulmonary nor renal pathology and recruited at the clinical investigation centre of the CHU of Tours.

Conditions

  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex

Interventions

OTHER

24h urine

Urine samples will be collected at home over 24 hours

OTHER

urine sample

A urine sample of 20cc will be collected

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Sylvain MARCHAND-ADAM · University Hospital, Tours

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2022-10-30
Completion
2022-10-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05323370 on ClinicalTrials.gov